These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23507037)

  • 41. Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection.
    Gulin JE; Eagleson MA; Postan M; Cutrullis RA; Freilij H; Bournissen FG; Petray PB; Altcheh J
    J Antimicrob Chemother; 2013 Apr; 68(4):888-94. PubMed ID: 23212113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myocardial scars correlate with eletrocardiographic changes in chronic Trypanosoma cruzi infection for dogs treated with Benznidazole.
    Caldas IS; da Matta Guedes PM; dos Santos FM; de Figueiredo Diniz L; Martins TA; da Silva do Nascimento AF; Azevedo MA; de Lima WG; Neto RM; Torres RM; Talvani A; Bahia MT
    Trop Med Int Health; 2013 Jan; 18(1):75-84. PubMed ID: 23107306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy.
    Bustamante JM; Presti MS; Rivarola HW; Fernández AR; Enders JE; Fretes RE; Paglini-Oliva P
    Int J Antimicrob Agents; 2007 Jun; 29(6):733-7. PubMed ID: 17395432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
    Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dissimilar distribution of Trypanosoma cruzi clones in humans after chemotherapy with allopurinol and itraconazole.
    Coronado X; Zulantay I; Rozas M; Apt W; Sánchez G; Rodríguez J; Ortiz S; Solari A
    J Antimicrob Chemother; 2006 Jul; 58(1):216-9. PubMed ID: 16717054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.
    Ferraz ML; Gazzinelli RT; Alves RO; Urbina JA; Romanha AJ
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1359-64. PubMed ID: 17220408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
    Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic action of MK-436 (2,5-nitroimidazole) on Trypanosoma cruzi infections in mice: a parasitological, serological, histopathological, and ultrastructural study.
    Andrade SG; Silva RC; Santiago CM; Freitas LA
    Bull World Health Organ; 1987; 65(5):625-33. PubMed ID: 3123082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase chain reaction in mice.
    Basombrío MA; Segura MA; Nasser JR
    J Parasitol; 2002 Dec; 88(6):1107-12. PubMed ID: 12537102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
    Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
    Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions.
    Vilar-Pereira G; Silva AA; Pereira IR; Silva RR; Moreira OC; de Almeida LR; de Souza AS; Rocha MS; Lannes-Vieira J
    Brain Behav Immun; 2012 Oct; 26(7):1136-49. PubMed ID: 22841695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy.
    Simões-Silva MR; De Araújo JS; Oliveira GM; Demarque KC; Peres RB; D'Almeida-Melo I; Batista DGJ; Da Silva CF; Cardoso-Santos C; Da Silva PB; Batista MM; Bahia MT; Soeiro MNC
    Biochem Pharmacol; 2017 Dec; 145():46-53. PubMed ID: 28870526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of experimental chronic chagas disease with trifluralin.
    Zaidenberg A; Luong T; Lirussi D; Bleiz J; Del Buono MB; Quijano G; Drut R; Kozubsky L; Marron A; Buschiazzo H
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):351-6. PubMed ID: 16623857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-gamma in mediating parasitologic cure.
    Romanha AJ; Alves RO; Murta SM; Silva JS; Ropert C; Gazzinelli RT
    J Infect Dis; 2002 Sep; 186(6):823-8. PubMed ID: 12198617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo studies of 5-arylethenylbenzofuroxans in acute murine models of Chagas' disease.
    Boiani L; Davies C; Arredondo C; Porcal W; Merlino A; Gerpe A; Boiani M; Pacheco JP; Basombrío MA; Cerecetto H; González M
    Eur J Med Chem; 2008 Oct; 43(10):2229-37. PubMed ID: 18255195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi.
    Zuñiga C; Palau T; Penin P; Gamallo C; de Diego JA
    Trop Med Int Health; 1997 May; 2(5):482-7. PubMed ID: 9217704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs.
    Carneiro CM; Martins-Filho OA; Reis AB; Veloso VM; Araújo FM; Bahia MT; de Lana M; Machado-Coelho GL; Gazzinelli G; Correa-Oliveira R; Tafuri WL
    Acta Trop; 2007 Feb; 101(2):120-9. PubMed ID: 17296162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments.
    Diniz Lde F; Urbina JA; de Andrade IM; Mazzeti AL; Martins TA; Caldas IS; Talvani A; Ribeiro I; Bahia MT
    PLoS Negl Trop Dis; 2013; 7(8):e2367. PubMed ID: 23967360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enalapril in Combination with Benznidazole Reduces Cardiac Inflammation and Creatine Kinases in Mice Chronically Infected with Trypanosoma cruzi.
    Penitente AR; Leite AL; de Paula Costa G; Shrestha D; Horta AL; Natali AJ; Neves CA; Talvani A
    Am J Trop Med Hyg; 2015 Nov; 93(5):976-82. PubMed ID: 26350447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.